Amylyx Pharmaceuticals：Avexitide 定義內分泌領域的重組 (NASDAQ:AMLX)
· seekingalpha.com
Amylyx 轉向內分泌領域，其 avexitide 針對減重手術後低血糖症進行第三期 LUCIDITY 試驗；現金水位可維持至 2028 年。點擊此處閱讀更多。
Amylyx Pharmaceuticals ( AMLX ) is still frequently viewed through the lens of RELYVRIO (and ultimately the unsuccessful PHOENIX confirmatory trial) in ALS. How...